Summary
This 8-K filing from Anthem, Inc. (now Elevance Health) on December 22, 2014, primarily serves to reaffirm the company's full-year 2014 net income guidance. Investors should note that the company projected its net income to be within the range of $8.83 to $8.93 per share. This guidance includes favorable items recognized in the first nine months, with an adjusted net income expectation of $8.75 to $8.85 per share, excluding any further investment gains or losses beyond those already recorded. The reaffirmation of guidance suggests a level of confidence from management regarding the company's financial performance for the remainder of 2014. This filing is important for investors seeking to understand the company's near-term earnings expectations and assess potential risks or upside based on the provided per-share income ranges.
Key Highlights
- 1Anthem, Inc. (now Elevance Health) reaffirmed its full-year 2014 net income guidance.
- 2Projected net income for full year 2014 is in the range of $8.83 - $8.93 per share.
- 3The guidance includes $0.08 per share of net favorable items from the first nine months of 2014.
- 4Adjusted net income guidance, excluding these favorable items, is set between $8.75 - $8.85 per share.
- 5The guidance assumes no additional investment gains or losses beyond those recorded in the first nine months of 2014.
- 6The press release containing this information was furnished as an exhibit to the 8-K filing.